During the past decade, Algorithme Pharma Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Algorithme Pharma Inc." #1 sponsor was "Actavis Inc." with 2 trials, followed by "gicare Pharma Inc." with 2 trials sponsored, "Canopy Growth Corporation" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Par Pharmaceutical, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Algorithme Pharma Inc." #1 collaborator was "Algorithme Pharma Inc" with 3 trials as a collaborator, "Centre hospitalier de l'Université de Montréal (CHUM)" with 1 trials as a collaborator, "Galenova Inc" with 1 trials as a collaborator, "Hopital du Sacre-Coeur de Montreal" with 1 trials as a collaborator and "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Algorithme Pharma Inc." are "Healthy" (2 trials), "Cancer" (1 trials), "Colonic Disease" (1 trials), "Colonic Diseases" (1 trials) and "HBV" (1 trials). Many other conditions were trialed in "Algorithme Pharma Inc." in a lesser frequency.

Most popular intervention types in "Algorithme Pharma Inc." are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CelexaTM 40 mg tablets, single dose" (2 trials), "Citalopram HBr 40 mg tablets, single dose" (2 trials), "Placebo" (2 trials), "CHI-921" (1 trials) and "Flagyl" (1 trials). Other intervention names were less common.

The vast majority of trials in "Algorithme Pharma Inc." are 5 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Algorithme Pharma Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Algorithme Pharma Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Algorithme Pharma Inc., 6 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".